Foresite Capital Management I, LLC
Q2 2014 13F-HR Holdings
Net value change ($000)
-23,062
(-16.2%)
New positions
0
Sold out positions
2
Turnover %
23.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| KPTI | 15,134 | 30.9% |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 2,541 | 43.0% |
| XLRN | 1,173 | 162.7% |
| IGNYTA INC | 395 | 9.5% |
Top Reduces (Value $000, Stocks/ETFs)
| KERYX BIOPHARMACEUTICALS | -22,357 | -100.0% |
| TLPH | -7,871 | -47.5% |
| NVAX | -6,053 | -100.0% |
| AMBIT BIOSCIENCES CORP | -4,596 | -24.2% |
| OREXIGEN THERAPEUTICS INC | -400 | -4.9% |
| XNCR | -122 | -1.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|